製品名:N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide

IUPAC Name:N-{pyrazolo[1,5-a]pyridin-2-yl}acetamide

CAS番号:51119-07-4
分子式:C9H9N3O
純度:97%
カタログ番号:CM288851
分子量:175.19

包装単位 有効在庫 価格(USD) 数量
CM288851-1g 1-2 Weeks ưȺƎ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:51119-07-4
分子式:C9H9N3O
融点:-
SMILESコード:CC(NC1=NN2C=CC=CC2=C1)=O
密度:
カタログ番号:CM288851
分子量:175.19
沸点:
MDL番号:
保管方法:

Category Infos

Pyrazolopyridines
Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.

Product Other Information

Product Overview N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide, also known as PAP-1, is a small molecule compound that has gained significant attention in scientific research due to its potential therapeutic applications. PAP-1 is a potent and selective activator of the enzyme protein kinase R (PKR), which plays a crucial role in the regulation of various cellular processes.
Synthesis and Application The synthesis of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide involves the reaction of 2-aminopyridine with ethyl chloroacetate, followed by cyclization with hydrazine hydrate. The resulting product is then subjected to further reactions to yield the final compound, N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide. N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide has been extensively studied in scientific research for its potential therapeutic applications. It has been shown to have anti-inflammatory, anti-viral, and anti-tumor properties. N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide has been found to be effective in the treatment of various diseases, including cancer, viral infections, and autoimmune disorders.
Future Directions There are several future directions for the research on N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide. One potential direction is to investigate the use of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide in the treatment of autoimmune disorders, such as multiple sclerosis and rheumatoid arthritis. Another direction is to explore the use of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide in combination with other drugs to enhance their efficacy in the treatment of cancer and viral infections. Additionally, further studies are needed to elucidate the precise mechanism of action of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide and its potential side effects.